SIX Swiss Exchange · Healthcare
Invest in Sandoz stock from India
Indian and foreign residents can buy Sandoz (SDZ) shares directly through Paasa.
By Paasa · Updated
Sandoz at a glance
- Price
- CHF 69.32-CHF 1.42 (2.01%)
- Market cap
- CHF 29.99B
- Day range
- CHF 69.20 – CHF 70.50
- P/E
- 55.96
- Dividend yield
- 1.15%
- Volume
- 799.26K
- 1 month
- +1.64%
- 6 months
- +6.12%
- YTD
- +19.85%
- 1 year
- +42.81%
- 5 years
- —
Sandoz statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $11.2B | $9.1B | $10.0B | $9.3B | $9.7B |
| Gross profit | $5.3B | $4.9B | $4.6B | $4.4B | $4.2B |
| Operating income | $1.4B | $307.0M | $375.0M | $1.2B | $1.5B |
| Net income | $957.5M | $1.0M | $77.0M | $848.0M | $828.4M |
| Earnings per share | $2.12 | $0.00 | $0.18 | $1.97 | $1.92 |
| EBITDA | $2.3B | $727.5M | $857.0M | $1.7B | $1.8B |
| Total assets | $22.0B | $19.9B | $19.4B | $17.6B | $16.0B |
| Total debt | $5.7B | $4.9B | $4.6B | $309.0M | $284.3M |
| Cash and short-term investments | $1.7B | $1.2B | $933.4M | $74.0M | $36.4M |
| Shareholders' equity | $9.4B | $8.2B | $7.3B | $77.1K | $7.4B |
| Operating cash flow | $1.6B | $656.0M | $325.3M | $1.2B | $1.2B |
| Free cash flow | $810.0M | $60.0M | −$242.6M | $760.2M | $855.8M |
| Capital expenditure | −$784.0M | −$596.0M | −$567.9M | −$407.8M | −$382.2M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in USD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA.NS | $1,759.80 | $4.22T |
| Torrent Pharmaceuticals | TORNTPHARM.NS | $4,617.10 | $1.76T |
| Cipla | CIPLA.NS | $1,306.80 | $1.06T |
| Dr. Reddy's Laboratories | DRREDDY.NS | $1,180.00 | $982.94B |
| Mankind Pharma | MANKIND.NS | $2,380.00 | $982.93B |
| Aurobindo Pharma | AUROPHARMA.NS | $1,645.00 | $946.50B |
| Lupin | LUPIN.NS | $1,936.90 | $885.62B |
| Teva Pharmaceutical Industries | TEVA.TA | $11,770.00 | $137.08B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Sandoz from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search SDZ and buy
Find Sandoz by name or by its ticker, SDZ, and place your order.
Why invest in Sandoz from India
What Sandoz does
Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Sandoz stock from India?
Yes. Indian residents and NRIs can buy Sandoz (SDZ) shares directly through Paasa. Sandoz is listed on the SIX Swiss Exchange, in the Drug Manufacturers - Specialty & Generic industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Sandoz shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.